Save
Email
Print
Share
RSS
Discovery Brings Hope of New Tailor-Made Anti-Cancer Agents
Scientists have tailor-made
a new chemical compound that
blocks a protein that has
been linked to poor
responses to treatment in
cancer patients. The
... > full story
Functional Ovarian Tissue Engineered in Lab
A proof-of-concept study
suggests the possibility of
engineering artificial
ovaries in the lab to
provide a more natural
option for hormone
... > full story
Origin of Aggressive Ovarian Cancer Discovered
Researchers have discovered
a likely origin of
epithelial ovarian cancer
(ovarian carcinoma), the
fifth leading cause of
cancer death among women in
... > full story
Nanotech'ed RNA Drug Reduces Ovarian Cancer Tumors by 83 Percent
By loading fragile RNA into
silicon nanoparticles,
researchers have found a new
drug delivery system can
reduce the size of ovarian
tumors by as much as 83
... > full story
Browse News Stories
1 to 10 of 373 stories
view headlines only
-
How Gold Nanoparticles Can Help Fight Ovarian Cancer
May 21, 2013 — Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Researchers found out why and determined how to make the ... > full story -
Hysterectomy Does Not Increase Risk of Cardiovascular Disease, Study Finds
May 14, 2013 — Having a hysterectomy with or without ovary removal in mid-life does not increase a woman's risk of cardiovascular disease compared to women who reach natural menopause, contrary to many previously ... > full story -
Markers Related to Ovarian Cancer Survival and Recurrence Identified
April 30, 2013 — Animal sciences researchers have identified biomarkers that are used to determine ovarian cancer survival and recurrence and shown how the interactions between these biomarkers affect these ... > full story -
Screening Detects Ovarian Cancer Using Neighboring Cells
April 22, 2013 — Pioneering biophotonics technology detects the early presence of ovarian cancer in humans by examining cells easily brushed from the neighboring cervix or uterus, not the ovaries themselves. The ... > full story -
Soy-Based Compound May Reduce Tumor Cell Proliferation in Colorectal Cancer
April 11, 2013 — Scientists have developed a soy-based treatment for colorectal cancer, a promising agent in ovarian cancer, and a new drug target for advanced prostate ... > full story -
Engineered T Cells Kill Tumors but Spare Normal Tissue in an Animal Model
April 7, 2013 — Researchers devised a next gen cancer immune approach in which the activation signal for T cells is physically dissociated from a second costimulatory signal for immune cells. The two CARs carry ... > full story -
Two-Step Ovarian Cancer Immunotherapy Made from Patients' Own Tumor Benefits Three Quarters of Trial Patients
April 7, 2013 — As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according to new ... > full story -
Targeted Toxin Active in Platinum-Resistant Ovarian Cancers
April 7, 2013 — Researchers have found that a novel antibody-guided drug achieves responses in platinum drug-resistant ovarian ... > full story -
New Type of Experimental Drug Active in Platinum-Resistant Ovarian Cancers
April 7, 2013 — The antibody-drug conjugate DMUC5754A, a novel member of a relatively new class of drugs, showed activity in women with ovarian cancer, even those with hard-to-treat, platinum-resistant disease, in a ... > full story -
Cisplatin-Resistant Cancer Cells Sensitive to Experimental Anticancer Drugs Called PARP Inhibitors
April 3, 2013 — Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a ... > full story
Search ScienceDaily
Number of stories in archives: 137,307
more 
